During the past decade, Lexitas conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lexitas" are "Dry Eye" (1 trials), "Dry Eye Disease" (1 trials) and "Glaucoma, Open-Angle" (1 trials). Many other conditions were trialed in "Lexitas" in a lesser frequency.

Most popular intervention types in "Lexitas" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "SY-201 Ophthalmic Solution 0.5%" (1 trials), "SY-201 Ophthalmic Solution 1.0%" (1 trials), "SY-201 Ophthalmic Solution 2.0%" (1 trials), "SY-201 Ophthalmic Solution Vehicle" (1 trials) and "VVN001 Ophthalmic Solution 1%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lexitas" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Lexitas". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Lexitas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lexitas, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".